Cardiovasc Diabetol 16:138 Uthman L, Homayr A, Juni RP, Spin EL, Kerindongo R, Boomsma M, Hollmann MW, Preckel B, Koolwijk P, van Hinsbergh VWM, Zuurbier CJ, Albrecht M, Weber NC (2019) Empagliflozin and Dapagliflozin Reduce ROS Generation and Restore NO Bioavailability in Tumor Necrosis Factor -Stimulated Human Coronary Arterial Endothelial Cells
The most recent STEP UP trial data shows even more promising results with higher-dose semaglutide ^1
Since growth hormone contributes to cell growth, I wouldnt prescribe these peptides to anyone with active cancer, where cell growth is already out of control
The weight loss drug boom and what it means for employers GLP-1 drug demand: What employers need to know Weight loss medications are changing the health care landscape
What is the average price of GLP-1 meds